| Wed, Jan 6, 2010 | | | OSI Pharmaceuticals to Present at the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12, 2010 Business Wire (Wed 11:38am)
| | Mon, Jan 4, 2010 | | | Biotech Calendar: Key Dates for January at TheStreet.com (Mon, Jan 4)
| | Thu, Dec 31, 2009 | | | 5-Star Stocks on the Upswing at Motley Fool (Thu, Dec 31)
| | Wed, Dec 30, 2009 | | | Pfizer Pflubs -- You Expected Otherwise? at Motley Fool (Wed, Dec 30)
| | Tue, Dec 29, 2009 | | | UPDATE - Pfizer ends late-stage lung-cancer study at Reuters (Tue, Dec 29)
| | | U.S. Patent and Trademark Office Grants Reissued Patent Replacing OSI Pharmaceuticals' Tarceva® Composition of Matter Patent Business Wire (Tue, Dec 29)
| | Mon, Dec 28, 2009 | | | 4-Star Stocks on the Upswing at Motley Fool (Mon, Dec 28)
| | Wed, Dec 23, 2009 | | | OSIP Narrows 2010 Revenue Guidance Zacks.com (Wed, Dec 23)
| | Tue, Dec 22, 2009 | | | OSI Pharmaceuticals trims 2010 revenue outlook AP (Tue, Dec 22)
| | | OSI Pharmaceuticals Updates Preliminary Revenue & Re-affirms Adjusted Earnings Growth Rate Guidance for 2010 Business Wire (Tue, Dec 22)
| | Fri, Dec 18, 2009 | | | Setback for OSIP's Tarceva Zacks.com (Fri, Dec 18)
| | Thu, Dec 17, 2009 | | | Biotech Stocks: Drug stocks chase broader market south at MarketWatch (Thu, Dec 17)
| | | Lilly to Benefit from OSI Rejection at Seeking Alpha (Thu, Dec 17)
| | | Aveo Pharma registers for potential IPO at bizjournals.com (Thu, Dec 17)
| | | Biotech Stocks: Drug stocks slip; OSI slides on FDA move at MarketWatch (Thu, Dec 17)
| | Wed, Dec 16, 2009 | | | Panel Rejects Early Use of Tarceva at The Wall Street Journal Online (Wed, Dec 16)
| | | UPDATE - US FDA panel rejects early use of Tarceva at Reuters (Wed, Dec 16)
| | | FDA panel votes down new use for OSI cancer drug AP (Wed, Dec 16)
| | | OSI Pharmaceuticals Announces Conference Call on ODAC Review of Tarceva® for Use as First-line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Business Wire (Wed, Dec 16)
| | | FDA Advisory Committee Recommends Against Approving Tarceva for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer Business Wire (Wed, Dec 16)
| Add OSIP News to My Yahoo!:

| |
|